Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
It’s time to change how we think about electroshock therapy
Electroconvulsive therapy is more effective than ketamine at treating severe depression, according to a new meta-analysis.
The missing apex of Maslow’s hierarchy could save us all
In his later years, psychologist Abraham Maslow added a new apex to the pyramid of human needs: self-transcendence.
Experimental “FLASH” cancer treatment aces first human trial
The first-in-human trial of FLASH radiotherapy found the experimental cancer treatment to be safe and effective.
Withdrawal symptoms from antidepressants can last over a year
A scientific review found that withdrawal symptoms from antidepressants and antipsychotics can last for over a year.
Merck pays Moderna $250m for personalized cancer vaccine
Pharma giant Merck has paid Moderna $250 million to co-develop and commercialize its promising mRNA-based personalized cancer vaccine.
Scientists discover slug that can decapitate itself, grow new body
Scientists observed two species of sea slug that were able to self-decapitate, survive for weeks without organs, and regenerate new bodies.
Deep brain stimulation can be life-altering for OCD sufferers when other treatment options fall short
Deep brain stimulation relies on thin electrodes implanted deep in the brain that deliver electrical currents. Could it treat OCD?
Five-minute breathing exercise can lower blood pressure
A simple breathing exercise called IMST can lower blood pressure as effectively as meds or aerobic exercise when done for five minutes a day.
Why does nature create patterns?
A physicist explains the molecular-level processes behind crystals, stripes, and basalt columns in nature.
New vaccine prevents 94% of severe RSV cases
UK drugmaker GSK’s RSV vaccine was nearly 95% effective at preventing severe infection in a phase 3 trial of older adults.
AI is able to spot diseases before symptoms appear
New AI tools are helping doctors screen healthy patients for diseases early, when treatments are most effective.
As Ebola reaches Ugandan capital, vaccines race to catch up
Caused by the Sudan strain of Ebola, current vaccines and therapies approved for Ebola won’t work in Uganda. But these might.
UK scientists solve a decades-long blood mystery
Researchers have discovered a new blood group which may have been behind the tragic loss of two babies.
Male birth control options are in development, but a number of barriers still stand in the way
A survey of over 9,000 men in nine countries found that over 55% would be willing to use a new method of male birth control.
Like genes, your gut microbes pass from one generation to the next
Not only did microbes diversify with their early modern human hosts as they traveled across the globe, they followed human evolution.
Genetically engineered bacteria make living materials for self-repairing walls and cleaning up pollution
With just an incubator and some broth, researchers can grow reusable filters made of bacteria to clean up pollution and more.
First-of-its-kind surgery may have helped reverse baby’s paralysis
The first recipient of a groundbreaking spina bifida treatment is now one year old and showing no signs of leg paralysis.
It may be possible to treat inherited blindness, even in adults
A new mouse study suggests that synthetic retinoids may be able to help restore vision in adults with Leber congenital amaurosis.
Walking to school is more likely to keep kids active as they age
Children who walk or bike to school at a young age are more likely to continue the habit as they age, a new study shows.
Cambridge researchers have discovered how cancer spreads
New research out of the University of Cambridge may have discovered a mechanism behind metastasis.
Subscribe to the newsletter